CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $64.56 USD
Updated Jul 1 6:40pm
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 3 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- CVS HEALTH Corp's market capitalization of $84,202,791,269 is ahead of 97.92% of US-listed equities.
- CVS's went public 34.52 years ago, making it older than 92.86% of listed US stocks we're tracking.
- Over the past twelve months, CVS has reported earnings growth of 167.28%, putting it ahead of 92.79% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to CVS HEALTH Corp, a group of peers worth examining would be SNE, HDB, MDLZ, AXP, and CI.
- Visit CVS's SEC page to see the company's official filings. To visit the company's web site, go to www.cvshealth.com.
CVS Stock Price Chart Technical Analysis Charts
CVS Price/Volume Stats
| Current price | $64.56 | 52-week high | $77.03 |
| Prev. close | $64.97 | 52-week low | $52.04 |
| Day low | $64.49 | Volume | 5,008,200 |
| Day high | $65.60 | Avg. volume | 9,474,388 |
| 50-day MA | $63.99 | Dividend yield | 3.1% |
| 200-day MA | $66.47 | Market Cap | 84.39B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $64.56 | $266.24 | 320% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for CVS HEALTH Corp. To summarize, we found that CVS HEALTH Corp ranked in the 76th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 321.67%. As for the metrics that stood out in our discounted cash flow analysis of CVS HEALTH Corp, consider:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 47. Its equity weight surpasses that of merely 14.3% of free cash flow generating stocks in the Healthcare sector.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than merely 3.21% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 311% |
| 1% | 315% |
| 2% | 320% |
| 3% | 324% |
| 4% | 328% |
| 5% | 332% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CVS, try HZNP, CCEL, ABC, TVTY, and MYL.
Loading social stream, please wait...